RANDOMIZED PHASE II STUDY OF NIVOLUMAB WITH OR WITHOUT IPILIMUMAB IN PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA

Type of Cancer
Skin and Soft Tissue

Site
Hackensack

Sponsor
Alliance

Protocol Number
A091401

To Learn More Call
201-510-0910